Leaflet: information for the user

Regulaten 600 mg film-coated tablets

eprosartán

Read this leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, consult your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.
• If you experience any side effects, consult your doctor, pharmacist or nurse, even if they are not listed in this leaflet. See section 4.

1. What is Regulaten and for what it is used

2. What you need to know before starting to take Regulaten

3. How to take Regulaten

4. Possible side effects

5. Storage of Regulaten

6. Contents of the pack and additional informationl

Regulatenis used for:

• treatment of hypertension.

Regulaten contains the active ingredient eprosartán.

• Eprosartánbelongs to a group of medicines known as “angiotensin II receptor inhibitors” and blocks the action of a substance called “angiotensin II”. This substance causes blood vessels to constrict, making it difficult for blood to pass through them, resulting in an increase in blood pressure. By blocking this substance, blood vessels relax and blood pressure decreases.

Do not take Regulaten:

• If you are allergic to the active ingredient or any of the other components of this medication (listed in section 6).
• If you have a severe liver disease.
• If you have severe kidney blood flow problems.
• If you are more than 3 months pregnant (it is also recommended not to take Regulaten at the beginning of pregnancy - see the "Pregnancy" section).
• If you have diabetes or kidney insufficiency and are being treated with a blood pressure-lowering medication containing aliskirén.

If you are in any of these cases, it is advisable to inform your doctor before starting treatment.

Warnings and precautions:

Consult your doctor, pharmacist, or nurse before starting to take Regulaten:

•If you have any other liver problems

•If you have any other kidney problems. The doctor will check your kidney function before starting treatment and periodically once treatment has started. They will also determine the concentrations of potassium, creatinine, and uric acid in the blood.

•If you have a heart problem such as coronary heart disease, heart failure, narrowing of the blood vessels or heart valves, or a muscle problem in the heart.

•If you produce too much of a hormone called "aldosterone".

•If you follow a low-sodium diet, take diuretics, or suffer from vomiting or diarrhea. This is because in these cases, a decrease in blood volume or sodium concentration in the blood may occur.

These situations must be corrected before taking Regulaten.

•If you are taking any of the following medications used to treat high blood pressure (hypertension):

-An angiotensin-converting enzyme inhibitor (ACE inhibitor) (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes.

-Aliskirén

Your doctor may need to monitor your kidney function, blood pressure, and electrolyte levels in the blood (e.g. potassium) at regular intervals.

See also the information under the heading "Do not take Regulaten".

• If you are taking any medication that may increase your serum potassium levels (see section "Taking Futuran with other medications").
• If you think you are (or may become) pregnant. Regulaten is not recommended for use at the beginning of pregnancy, and it should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby. See the "Pregnancy" and "Breastfeeding" sections.
• If you are a black patient, as this medication may be less effective in reducing blood pressure.

If you are in any of these cases (or are unsure), consult your doctor or pharmacist before taking Regulaten.

Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Regulaten.Your doctor will decide whether to continue treatment. Do not stop taking Regulaten on your own.

Children and adolescents:

Futuran should not be administered to children and adolescents under 18 years old.

Other medications and Regulaten:

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription. These include herbal remedies. This is because Regulaten may affect how other medications work, and these may affect how Regulaten works.

Specifically, inform your doctor or pharmacist if you are taking the following medications:

•Lithium, for mood problems. Your doctor should monitor your lithium blood concentration because Regulaten may increase it.

If this is your case (or you are unsure), consult your doctor or pharmacist before taking Regulaten.

The following medications may increase the effect of Regulaten:

•Medications that lower your blood pressure.

If this is your case (or you are unsure), consult your doctor or pharmacist before taking Regulaten.

The following medications may reduce the effect of Regulaten:

•Indometacin - for pain, stiffness, and swelling, and to reduce fever.

If this is your case (or you are unsure), consult your doctor or pharmacist before taking Regulaten

If you are taking any of the following medications, your doctor may need to perform blood tests:

•Medications containing potassium or potassium-sparing medications.

•Medications that increase potassium levels, such as heparin, trimetoprima, and ACE inhibitors.

Consult your doctor or pharmacist before taking Regulaten. Based on the results of your blood test, your doctor may decide to change your treatment with these medications or with Regulaten.

Your doctor may need to modify your dose and/or take other precautions:

If you are taking an ACE inhibitor or aliskirén (see also the information under the headings "Do not take Regulaten" and "Warnings and precautions").

Taking Regulaten with food:

•You can take the tablets with and without food.

•Consult your doctor before taking Regulaten if you follow a low-sodium diet. Not consuming enough salt may cause a decrease in blood volume or sodium concentration in the blood.

Pregnancy, breastfeeding, and fertility:

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Pregnancy:

Normally, before becoming pregnant, your doctor will replace Regulaten with another suitable antihypertensive medication. In general, your doctor will advise you to take another medication instead of Regulaten, as Regulaten is not recommended for use at the beginning of pregnancy (first 3 months) and should not be used in any case in the last 6 months of pregnancy, as it may cause serious harm to your baby.

Breastfeeding:

•Inform your doctor if you are breastfeeding or plan to start breastfeeding.

•Regulaten is not recommended for mothers who are breastfeeding. Your doctor may choose another treatment if you want to breastfeed, especially if your baby is newborn or premature.

Driving and operating machinery:

It is unlikely that Regulaten will affect your ability to drive or operate machinery. However, you may feel drowsy or dizzy while taking Regulaten. If this is your case, do not drive or use tools or machinery and inform your doctor.

Regulaten contains lactose.If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.

Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

How to Take This Medication

•Take this medication orally.

•Swallow the tablet whole with plenty of liquid, for example, with a glass of water.

•Do not crush or chew the tablets.

•Take the tablets in the morning, approximately at the same time each day.

Adults

The recommended dose is one tablet per day.

Use in Children and Adolescents

Regulaten should not be administered to children and adolescents under 18 years old.

If You Take More Regulaten Than You Should

If you take more Regulaten than you should or someone accidentally ingests it, consult your doctor or go to the hospital immediately. Bring the packaging and the medication leaflet with you. The following effects may occur:

•sensation of dizziness due to a drop in blood pressure (hypotension)

•nausea

•drowsiness

You can also consult the Toxicological Information Service, phone 91.562.04.20, indicating the medication and the amount ingested.

If You Forget to Take Regulaten

•If you forget to take a dose, take it as soon as you remember.

•If you forget to take a dose and it is close to the time of the next dose, do not take the missed dose. Do not take a double dose to make up for the missed doses.

If You Interrupt Treatment with Regulaten

Do not stop taking Regulaten without consulting your doctor first.

If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.

Like all medicines, this medicine may cause side effects, although not everyone will experience them. The following side effects may occur with this medicine:

Allergic reactions(may affect fewer than 1 in 100 people)

If you experience an allergic reaction, stop taking the medicine and seek medical attention immediately. The symptoms may include the following:

•skin reactions such as rash or hives with swelling (urticaria)

•swelling of the lips, face, throat, or tongue

•difficulty breathing

•swelling of the face or skin and mucous membrane (angioedema).

Other possible side effects

Very common (may affect more than 1 in 10 people)

•headache.

Common(may affect up to 1 in 10 people)

•dizziness.

•rash or itching (pruritus)

•nausea, vomiting, diarrhea

•weakness (asthenia)

•stuffy nose (rhinitis).

Uncommon(may affect up to 1 in 100 people)

•low blood pressure, including low blood pressure when standing. You may feel dizzy.

Unknown frequency(frequency that cannot be estimated from available data)

•kidney problems, including renal insufficiency.

•joint pain (arthralgia)

• intestinal angioedema: intestinal inflammation has been reported, presenting symptoms such as abdominal pain, nausea, vomiting, and diarrhea after use of similar products.

Reporting of side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

This medication does not require special storage conditions.

Do not use this medication after the expiration date that appears on the packaging, after CAD or EXP. The expiration date is the last day of the month indicated.

Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.

Composition of Regulaten

• The active ingredient is eprosartan. Each coated tablet contains 600 mg of eprosartan (in the form of dihydrous mesilate).
• The other components (excipients) are: lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch without gluten, crospovidone, magnesium stearate, hypromellose, titanium dioxide (E 171), macrogol 400, and polisorbate 80.

Appearance of the product and contents of the packaging

White oval-shaped tablets with the inscription 5046 on one side.

Regulaten is packaged in opaque PVC/PCTFE blisters, in boxes containing 28 tablets.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization:

Viatris Healthcare Limited

Damastown Industrial Park

Mulhuddart, Dublin 15

Dublin

Ireland

Responsible for manufacturing:

Mylan Laboratories SAS

Route de Belleville Lieu dit Maillard

F-01400 Châtillon sur Chalaronne (France)

Tel.: +33 4 74 45 54 42

Fax: +33 4 74 55 02 83

You can request more information about this medication by contacting the local representative of the holder of the marketing authorization:

Viatris Pharmaceuticals, S.L.

C/ General Aranaz, 86

28027 Madrid

Spain

Last review date of this leaflet:January 2025

The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/